BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Policy

  Helius Medical Technologies Announces Health Canada Approval To Start Investigational Testing For The Pons™ Device

  October 2, 2014

   · 

  1 min read
• BioMidwest

  Sterigenics International, Inc. Release: SteriPro Consulting Director To Serve As Trainer At Radiation Sterilization For Medical Devices Program

  October 2, 2014

   · 

  1 min read
• Deals

  Stemgent, Inc. Sells The Stem Cell Reagent And Services Business Unit

  October 2, 2014

   · 

  1 min read
• Pharm Country

  National MS Society Invests Nearly $19 Million In New Research To Stop Multiple Sclerosis, Restore Function And End MS Forever

  October 2, 2014

   · 

  4 min read
• Horizon Pharma plc. Announces The U.S. Patent And Trademark Office Issuance Of Additional Notice Of Allowance With Claims Covering VIMOVO(R) (naproxen/esomeprazole) Delayed Release Tablets

  October 2, 2014

   · 

  3 min read
• Pharm Country

  Aclaris Therapeutics Locks In $21 Million Series B Financing

  October 2, 2014

   · 

  4 min read
• Business

  AB SCIEX And Illumina, Inc. Collaborate To Create World’s First Multi-omics Cloud-Computing Environment

  October 2, 2014

   · 

  1 min read
• Business

  Boston Therapeutics, Inc. Appoints Jan Brinkman, M.D., Ph.D. And Alan M. Hoberman, Ph.D. To Board Of Directors

  October 2, 2014

   · 

  5 min read
• Pharm Country

  Moberg Pharma AB (Formerly known as Moberg Derma) Awarded $3 Million to Develop “Smart Neuro ICU” Medical Technology

  October 2, 2014

   · 

  2 min read
• Business

  Theraclion 2014 Interim Results

  October 2, 2014

   · 

  6 min read